Moloney Securities Asset Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.23M Sell
44,575
-5,575
-11% -$154K 0.15% 161
2025
Q1
$1.42M Buy
50,150
+45,296
+933% +$1.28M 0.19% 131
2024
Q4
$202K Sell
4,854
-5,406
-53% -$225K 0.03% 416
2024
Q3
$686K Buy
10,260
+4,419
+76% +$295K 0.09% 238
2024
Q2
$694K Sell
5,841
-4,704
-45% -$559K 0.1% 222
2024
Q1
$1.12M Buy
10,545
+2,734
+35% +$291K 0.17% 147
2023
Q4
$777K Buy
7,811
+1,850
+31% +$184K 0.12% 192
2023
Q3
$616K Sell
5,961
-113
-2% -$11.7K 0.11% 209
2023
Q2
$738K Sell
6,074
-3,882
-39% -$472K 0.13% 188
2023
Q1
$1.53M Sell
9,956
-2,423
-20% -$372K 0.28% 95
2022
Q4
$2.22M Buy
12,379
+718
+6% +$129K 0.49% 53
2022
Q3
$1.38M Buy
11,661
+775
+7% +$91.7K 0.33% 78
2022
Q2
$1.56M Sell
10,886
-4,450
-29% -$636K 0.36% 77
2022
Q1
$2.64M Buy
15,336
+1,968
+15% +$339K 0.51% 50
2021
Q4
$3.4M Buy
13,368
+125
+0.9% +$31.7K 0.58% 38
2021
Q3
$5.1M Sell
13,243
-4,620
-26% -$1.78M 0.93% 20
2021
Q2
$4.2M Buy
17,863
+7,375
+70% +$1.73M 0.76% 28
2021
Q1
$1.37M Buy
10,488
+815
+8% +$107K 0.27% 98
2020
Q4
$1.01M Sell
9,673
-412
-4% -$43.1K 0.22% 119
2020
Q3
$714K Sell
10,085
-10,325
-51% -$731K 0.19% 135
2020
Q2
$1.31M Sell
20,410
-15,155
-43% -$973K 0.38% 85
2020
Q1
$1.07M Sell
35,565
-635
-2% -$19K 0.38% 82
2019
Q4
$708K Sell
36,200
-102,750
-74% -$2.01M 0.22% 131
2019
Q3
$2.21M Buy
138,950
+83,875
+152% +$1.34M 0.74% 33
2019
Q2
$806K Buy
55,075
+3,437
+7% +$50.3K 0.27% 116
2019
Q1
$1.05M Buy
+51,638
New +$1.05M 0.36% 81